The Global Automated External Defibrillator Market Is Witnessing High Growth Owing To the High Rate of Development by Key Players in the World

Automated External Defibrillator Market

Automated External Defibrillator Market, By Analysis Type (Semi-automated External Defibrillators and Fully-automated External Defibrillators) By End User (Hospitals/Clinics, Home Care, and Other End Users), and By Geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028.

The Automated External Defibrillator (AED) is a device that can help to save lives by delivering an electrical shock to a person who is experiencing sudden cardiac arrest. It is portable and can be used in any setting, including at home, the workplace, and in schools. Automated external defibrillators are medical devices that analyze a person's heart rhythm and then give the operator instructions for performing CPR and delivering a shock. Those who need to learn how to use an AED should enroll in a CPR/AED training course. This is an important step because cardiac arrest is a life-threatening emergency. An automated external defibrillator is a small, portable device that can deliver a high-energy electric shock to a person who is having a heart attack. They are often kept in ambulances or public places.

The global Automated External Defibrillator Market was valued at US$ 717.5 Mn in 2021 and is forecast to reach a value of US$ 1,217.0 Mn by 2028 at a CAGR of 7.8% between 2022 and 2028.

Competitive Landscape:

Major players operating in the global automated external defibrillator market include Schiller AG, Progetti SRL – Medical Equipment Solutions, Mindray Medical International Ltd., Mediana Co. Ltd., METsis Medikal, CU Medical Systems, BIOTRONIK, MicroPort, Nihon Kohden, Abbott, Boston Scientific Corporation, Asahi Kasei Corporation, Koninklijke Philips N.V., Stryker Corporation, and Medtronic.

Key Market Drivers:

Increasing developments in the global market are expected to augment the growth of the market. For instance, in August 2022, Portage Health Foundation introduced a one-time automated external defibrillator (AED) grant program, in order to address the company's long-term sustainability goal of developing better and safer communities. An AED is designed to be easy to operate. The device comes with all the necessary accessories for delivering a shock. Before using the AED, it is important to clean the electrode pads, remove any moisture, and make sure all the batteries are in good condition. Moreover, the high incidence of cardiovascular issues in the world is estimated to enhance the growth of the global market.

Covid-19 Impact Analysis:

During the COVID-19 pandemic, there have been several developments in the global automated external defibrillator market. For instance, in April 2021, Respicardia, Inc. was acquired by ZOLL Medical Corporation. This acquisition will aid the company to expand in several areas such as cardiopulmonary resuscitation, and heart failure.

Key Takeaways:

· North America is expected to dominate the growth of the global automated external market, owing to the high developments by key market players in the region. For instance, in July 2020, the United States Food and Drug Administration gave approval to Abbott, for the company's next-generation CRT-Ds and ICDs under Gallant, the brand name.

· The Asia Pacific is estimated to witness high growth in the global automated external market, owing to the high expansion of key players in the region. For instance, in June 2020, Asahi Kasei Corporation updated the company's Zoll AED 3 defibrillator, along with wireless connectivity features, integrated child rescue, and real CPR.